Literature DB >> 4296905

Murine cytomegalovirus: observations on growth in vitro, cytopathic effect, and inhibition with 5-Iododeoxyuridine.

D Henson, R D Smith, J Gehrke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4296905     DOI: 10.1007/bf01246575

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  16 in total

1.  THE EFFECT OF 5-BROMODEOXYURIDINE ON HERPES SIMPLEX INFECTION OF HELA CELLS.

Authors:  P SIMINOFF
Journal:  Virology       Date:  1964-09       Impact factor: 3.616

2.  A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS.

Authors:  G PLUMMER; M BENYESH-MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

3.  EFFECT OF AMINOPTERIN ON THE REPLICATION OF THE MURINE SALIVARY GLAND VIRUS.

Authors:  D HENSON; H PINKERTON
Journal:  Nature       Date:  1964-04-25       Impact factor: 49.962

4.  MOUSE CYTOMEGALOVIRUS INFECTION. AN ELECTRON MICROSCOPIC STUDY OF HEPATIC PARENCHYMAL CELLS.

Authors:  B H RUEBNER; K MIYAI; R J SLUSSER; P WEDEMEYER; D N MEDEARIS
Journal:  Am J Pathol       Date:  1964-05       Impact factor: 4.307

5.  SPREAD OF ZOSTER VIRUS IN HUMAN EMBRYONIC LUNG CELLS AND THE INHIBITORY EFFECT OF LODODEOXYURIDINE.

Authors:  F RAPP; D VANDERSLICE
Journal:  Virology       Date:  1964-03       Impact factor: 3.616

6.  THE IMMUNOFLUORESCENT FOCUS TECHNIQUE IN STUDYING THE REPLICATION OF CYTOMEGALOVIRUS.

Authors:  F RAPP; L E RASMUSSEN; M BENYESH-MELNICK
Journal:  J Immunol       Date:  1963-11       Impact factor: 5.422

7.  A MORPHOLOGIC COMPARISON BETWEEN THE DEVELOPMENTAL STAGES OF HERPES ZOSTER AND HUMAN CYTOMEGALOVIRUS.

Authors:  P BECKER; J L MELNICK; H D MAYOR
Journal:  Exp Mol Pathol       Date:  1965-02       Impact factor: 3.362

8.  Fluorescence microscopy in the study of nucleic acids; histochemical observations on cellular and virus nucleic acids.

Authors:  J A ARMSTRONG; J S NIVEN
Journal:  Nature       Date:  1957-12-14       Impact factor: 49.962

9.  Use of antimetabolites in the study of normal and abnormal cell structure and function.

Authors:  R Love; G P Studzinski; K A Ellem
Journal:  Fed Proc       Date:  1965 Sep-Oct

10.  The rate of formation of vaccinia deoxyribonucleic acid and vaccinia virus.

Authors:  N P SALZMAN
Journal:  Virology       Date:  1960-01       Impact factor: 3.616

View more
  8 in total

1.  Cell cycle dependency of murine cytomegalovirus replication in synchronized 3T3 cells.

Authors:  M T Muller; J B Hudson
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

Review 2.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Murine cytomegalovirus infection in a non-permissive line of mouse fibroblasts.

Authors:  V Misra; J B Hudson
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

4.  Cerebral form of generalized cytomegaly of early infancy. Light and electron microscopic findings.

Authors:  A P Anzil; K Blinzinger; S Dozić
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

5.  Non-fatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations.

Authors:  D Henson; R D Smith; J Gehrke
Journal:  Am J Pathol       Date:  1966-11       Impact factor: 4.307

6.  Isolation of a cytomegalovirus-like agent from wild rats.

Authors:  C A Bruggeman; H Meijer; P H Dormans; W M Debie; G E Grauls; C P van Boven
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  [Mouse cytomegalovirus infection under cytosine arabinoside treatment].

Authors:  P Peller; O Goetz; M Rath
Journal:  Infection       Date:  1976       Impact factor: 3.553

8.  The M25 gene products are critical for the cytopathic effect of mouse cytomegalovirus.

Authors:  Ivana Kutle; Sarah Sengstake; Corinna Templin; Mandy Glaß; Tobias Kubsch; Kirsten A Keyser; Anne Binz; Rudolf Bauerfeind; Beate Sodeik; Luka Čičin-Šain; Martina Dezeljin; Martin Messerle
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.